Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-negative bacterial outer membrane lipopolysaccharide (LPS) core is a complex oligosaccharide region that links the membrane-anchored lipid A to the peripheral O-antigen [1]. It is structurally divided into an inner core, characterized by unique sugars like 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), and an outer core composed of more common hexoses [2]. This region is vital for the structural integrity of the bacterial outer membrane and acts as a selective permeability barrier against toxic hydrophobic molecules and host immune factors [2]. Because the inner core is highly conserved across many pathogenic Gram-negative species, it represents a significant target for the development of broad-spectrum antibiotics and neutralizing antibodies [5]. Therapeutic agents such as polymyxins bind to the LPS core and lipid A, displacing stabilizing divalent cations and leading to membrane disruption and bacterial cell death [3]. Despite its potential, targeting the LPS core in clinical settings like sepsis has proven challenging due to the complex inflammatory cascades triggered by endotoxin release [5]. Sources: [1] Raetz & Whitfield (2002) Ann. Rev. Biochem.; [2] Bertani & Ruiz (2018) EcoSal Plus; [3] PubChem (2024) Polymyxin B; [4] NIH/StatPearls (2023) Gram-Negative Bacteria; [5] Opal (2010) Int. J. Med. Microbiol.
Displacement of divalent cations (Mg2+ and Ca2+) from the LPS core and lipid A, leading to outer membrane destabilization, increased permeability, and eventual cell lysis [3].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-negative bacterial outer membrane lipopolysaccharide core (LPS core).